Fibromyalgia, dental health, and inflammation in the Covid-19 pandemia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00029720

Enrollment

160

Registered

2022-07-20

Start date

2022-07-21

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K05 M79.7

Interventions

Group 1: Patients with FMS: with periodontitis Group 2: Patients with FMS: without periodontitis Group 3: Patients undergoing treatment for periodontal diseases

Eligibility

Sex/Gender

Female

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: Female patients aged between 18 and 85 years with FMS according to ACR criteria. Female controls aged between 18 and 85 years without FMS who report to the Department of Periodontology for periodontal disease screening.

Exclusion criteria

Exclusion criteria: Serious other illness that would prevent participation in the study.

Design outcomes

Primary

Measure	Time frame
Proinflammatory cytokine levels in saliva	—

Secondary

Measure	Time frame
Proinflammatory cytokine levels in serum	—

Countries

Germany

Contacts

Public ContactClaudia Sommer

Neurologische Klinik und Poliklinik

sommer@uni-wuerzburg.de0931/2010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026